Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 224-675-8 | CAS number: 4443-26-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics in vivo
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Test procedure in accordance with generally accepted scientific standards and described in sufficient detail. No deficiencies.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 994
Materials and methods
- Objective of study:
- other: To evaluate the toxicokinetics of 14C PAC in the rat. The fate and disposition of 14C in the rat tissues was followed by whole body autoradiography (WBA).
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- 8 male and 8 female CD rats were dosed with 2.56 mg [14C]-labeled PAC by gavage. The distribution of the test substance was studied by WBA analysis. Excretion of radioactivity was followed over 4 days after dosing in urine, faeces and exhaled air. TLC and HPLC analyses were carried out on the urine samples for the detection of possible metabolites.
- GLP compliance:
- yes
Test material
- Reference substance name:
- 1,3-dihydro-1,3-dioxo-2H-isoindole-2-hexanoic acid
- EC Number:
- 224-675-8
- EC Name:
- 1,3-dihydro-1,3-dioxo-2H-isoindole-2-hexanoic acid
- Cas Number:
- 4443-26-9
- Molecular formula:
- C14H15NO4
- IUPAC Name:
- 6-(1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl)hexanoic acid
- Details on test material:
- Lot/Batch number: S2015901
Specific activity: 8.87 μCi/mg
Purity: > 98% w/w
Details of label: C14 (carbonyl) labelled phthalic anhydride was reacted with caprolactam, so to obtain C14 labelled PAC.
Constituent 1
- Radiolabelling:
- yes
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River
- Age at study initiation: not reported
- Weight at study initiation: males 236-270 g; females 215-246 g
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- other: ethanol and 10% Tween 80 solution in distilled water
- Details on exposure:
- Labeled PAC was dissolved in ethanol (51.2 mg in 2 ml) and diluted to 18 ml with a 10% solution of Tween 80 in distilled water.
Concentration in vehicle: 2.56 mg/ml (22.7 μCi/ml).
Total volume administered: 1 ml. - Duration and frequency of treatment / exposure:
- Single treatment
Doses / concentrations
- Remarks:
- Doses / Concentrations:
2.56 mg/animal (22.7 μCi/animal)
- No. of animals per sex per dose / concentration:
- Male: 8 animals at 2.56 mg/animal = 22.7 μCi/animal
Female: 8 animals at 2.56 mg/animal = 22.7 μCi/animal - Control animals:
- not specified
- Details on dosing and sampling:
- Samples:
Expired air, urine and faeces were collected/sampled as follows:
- Urine: At 8, 24, 72 and 96 hours
- Faeces: At 24, 48, 72 and 96 hours
- Expired air: At 2, 4, 8 and 24 hours.
Observations:
At 4, 8, 24, 48 and 96 hours one male and one female rat were weighed and sacrificed and prepared for whole body autoradiography (WBA). After 96 ours, heart blood was withdrawn from the remaining animals, whose carcasses were prepared for 14C analysis.
Throughout the study 14C activity was determined by liquid scintillation counting. Urine samples were analysed by TLC and HPLC for the detection of metabolites.
Results and discussion
Toxicokinetic / pharmacokinetic studies
- Details on absorption:
- The 14C was extensively and rapidly absorbed from the gut, then rapidly excreted.
- Details on distribution in tissues:
- WBA showed similar tissue distribution. The tissues showing the highest levels of 14C were those associated with the major routes of excretion (liver - including bile ducts, kidney, bladder and intestinal tract). Other tissues showing low levels of radioactivity were the lungs, heart, muscle, testis, nasal turbinates, salivary gland and brown fat. After 24 hours only low levels of radioactivity remained, being confined to the liver, kidney and intestine At 48 and 96 hours all the organs and tissues are at background levels indicating that there is not accumulation or retention of the chemical.
- Details on excretion:
- The major route of excretion was in the urine, with approximately 90 - 92 % (males - females) of the dose accounted for in 96 hours with the majority excreted in the first 24 hours. Excretion via the faeces in 96 hours accounted for another 8 - 5 % (males - females) of the dose. The majority of the faecal 14C was in the first 24 hours in the male rats and in the 24 -72 hour period in the female rats. No exhalation of 14C CO2 was detected and no radioactivity was detected in samples of circulating blood. Only 1-2% of the administered dose was present in the carcase after 96 hours.
Metabolite characterisation studies
- Metabolites identified:
- no
- Details on metabolites:
- Chromatographic analysis (HPLC and TLC) of urine showed there to be at least six products of metabolism of which two accounted for approximately 80% of total urinary 14C. There did not appear to be any parent material present. The identity of the metabolism products was not established but they appeared to be the same as the test substance’s degradation products in urine (cfr. Section A6.2.3).
Any other information on results incl. tables
Mean 14C recovery (%) from rats dosed by gavage with labeled 6 -(phthalimido)hexanoic acid
|
CO2 |
Urine |
Faeces |
Cage wash |
Blood |
Carcass |
Total recovery |
||||||||
Day 1 |
Day 1 |
Day 2 |
Day 3 |
Day 4 |
Total |
Day 1 |
Day 2 |
Day 3 |
Day 4 |
Total |
|||||
Males |
0.00* |
88 |
1.6 |
0.29 |
0.14 |
90 |
7.15 |
0.51 |
0.06 |
0.03 |
7.75 |
0.18 |
0.00* |
1.24 |
99.03 |
Females |
0.00* |
80 |
9.4 |
1.73 |
0.45 |
92 |
0.11 |
0.60 |
4.66 |
0.10 |
5.47 |
0.26 |
0.00* |
1.28 |
98.97 |
14C recovery (%) from rats dosed by gavage with labeled 6 -(phthalimido)hexanoic acid -- WBA results
|
Sacrifice time (h) |
CO2 |
Total Urine |
Total Faeces |
Cage wash |
Total recovery |
Males |
4 |
0.00* |
32.48 |
0.03 |
5.37 |
37.88 |
8 |
0.00* |
58.29 |
8.22 |
5.82 |
72.33 |
|
24 |
0.00* |
94.21 |
4.78 |
2.04 |
101.03 |
|
48 |
0.00* |
91.72 |
4.70 |
0.69 |
97.11 |
|
96 |
0.00* |
107.41 |
5.83 |
0.43 |
113.67 |
|
Females |
4 |
0.00* |
21.58 |
0.24 |
3.07 |
24.89 |
8 |
0.00* |
53.40 |
0.04 |
9.16 |
62.60 |
|
24 |
0.00* |
88.77 |
8.64 |
1.10 |
98.51 |
|
48 |
0.00* |
70.66 |
2.75 |
0.060.35 |
73.76 |
|
961 |
0.00* |
53.01 |
2.10 |
4.660.23 |
55.34 |
Applicant's summary and conclusion
- Conclusions:
- PAC is rapidly absorbed from the gut and rapidly excreted via the urine. No tissue retention was observed. PAC completely metabolised before the excretion.
- Executive summary:
8 male and 8 female CD rats were dosed with 2.56 mg [14C]-labeled PAC by gavage. The distribution of the test substance was studied by WBA analysis. Excretion of radioactivity was followed over 4 days after dosing in urine, faeces and exhaled air. TLC and HPLC analyses were carried out on the urine samples for the detection of possible metabolites.
Rapid absorption and excretion of the test substance were observed. Urine was the main excretion route with 90-92% of the total dose excreted within 96 hours. 8-5% of the radioactivity were excreted via faeces within the first 24 hours. No radioactivity was detected in the exhaled air. After 96 hours only 1-2% of the administered radioactivity was detected in the carcass, mainly present in tissue related to the excretion routes. No parent compound was detected in the metabolite analysis of excreted urine. At least six metabolites were detected, of which two accounted for approximately 80% of total urinary14C.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.